Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)
Status:
Completed
Trial end date:
2018-10-23
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate safety, tolerability, and pharmacokinetics of a single
1200-mg dose of raltegravir (MK-0518, ISENTRESS®) in healthy Japanese male participants.